首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Nar cancer

缩写:

ISSN:2632-8674

e-ISSN:2632-8674

IF/分区:3.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引318
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Marcello Germoglio,Federica D&#x;Aria,Giuseppe Cortone et al. Marcello Germoglio et al.
G-quadruplex (G4) DNAs are alternative nucleic acid structures, proposed to play important roles in regulating DNA replication, gene transcription, and translation. Several specialized DNA helicases are involved in cellular G4 metabolism, i...
Kirti Sad,Dorelle V Fawwal,Celina Y Jones et al. Kirti Sad et al.
Sequencing of human patient tumors has identified recurrent missense mutations in genes encoding core histones. We report that mutations that convert histone H3 amino acid 50 from a glutamate to a lysine (H3E50K) support an oncogenic phenot...
Chloé Morin,Hermes Paraqindes,Flora Nguyen Van Long et al. Chloé Morin et al.
The epithelial-mesenchymal transition (EMT) is a dynamic transdifferentiation of epithelial cells into mesenchymal cells. EMT programs exhibit great diversity, based primarily on the distinct impact of molecular activities of the EMT transc...
Benjamin Ahn,Charissa Chou,Caden Chou et al. Benjamin Ahn et al.
Cancer is a complex disease with heterogeneous mutational and gene expression patterns. Subgroups of patients who share a phenotype might share a specific genetic architecture including protein-protein interactions (PPIs). We developed the ...
María José Jiménez-Santos,Santiago García-Martín,Marcos Rubio-Fernández et al. María José Jiménez-Santos et al.
Breast cancer patients are categorized into three subtypes with distinct treatment approaches. Precision oncology has increased patient outcomes by targeting the specific molecular alterations of tumours, yet challenges remain. Treatment fa...
Francien Talens,Vivian Oliviera Nunes Teixeira,Yannick P Kok et al. Francien Talens et al.
Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPis) are currently used to treat BRCA1/2 mutant cancers. Although PARPi sensitivity has been attributed to homologous recombination (HR) defects, other roles of HR factors have also been lin...
Ian R Sturgill,Jesse R Raab,Katherine A Hoadley Ian R Sturgill
Aberrant expression of the BAP1 (BRCA associated protein 1) tumor suppressor gene is a prominent risk factor for several tumor types and is important in tumor evolution and progression. Here we performed integrated multi-omics analyses usin...
Jing-Fang Luo,Shijia Wang,Jiajing Fu et al. Jing-Fang Luo et al.
Transcription factor EB (TFEB) mainly regulates the autophagy-lysosomal pathway, associated with many diseases, including cancer. However, the role of TFEB in pan-cancer has not been investigated systematically. In this study, we comprehens...
Carolina Persico,Nunzia Iaccarino,Francesca Romano et al. Carolina Persico et al.
The use of chemotherapeutics has achieved considerable success in cancer therapy; however, their toxicity can severely impact patients' health. In this study, aiming to reduce the doses and potential side effects of traditional chemotherape...
Shen-Hsi Yang,Ibrahim Ahmed,Yaoyong Li et al. Shen-Hsi Yang et al.
Cancer is a disease underpinned by aberrant gene expression. Enhancers are regulatory elements that play a major role in transcriptional control and changes in active enhancer function are likely critical in the pathogenesis of oesophageal ...